These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 37438601)

  • 21. Ferroptosis: a critical mechanism of N
    Wei Q; Xue C; Li M; Wei J; Zheng L; Chen S; Duan Y; Deng H; Tang F; Xiong W; Zhou M
    Sci China Life Sci; 2024 Jun; 67(6):1119-1132. PubMed ID: 38811442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long noncoding RNAs induced control of ferroptosis: Implications in cancer progression and treatment.
    Shi W; Sethi G
    J Cell Physiol; 2023 May; 238(5):880-895. PubMed ID: 36924057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ChIP and ChIRP Assays in Ferroptosis.
    Wang Z; Tao T; Tao Y
    Methods Mol Biol; 2023; 2712():19-27. PubMed ID: 37578693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferroptosis Induction in Multiple Myeloma Cells Triggers DNA Methylation and Histone Modification Changes Associated with Cellular Senescence.
    Logie E; Van Puyvelde B; Cuypers B; Schepers A; Berghmans H; Verdonck J; Laukens K; Godderis L; Dhaenens M; Deforce D; Vanden Berghe W
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Ferroptosis Pathways: A Novel Strategy for Cancer Therapy.
    Maru D; Hothi A; Bagariya C; Kumar A
    Curr Cancer Drug Targets; 2022; 22(3):234-244. PubMed ID: 35152865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.
    Zhang X; Sui S; Wang L; Li H; Zhang L; Xu S; Zheng X
    J Cell Physiol; 2020 Apr; 235(4):3425-3437. PubMed ID: 31556117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors.
    Madkour MM; Ramadan WS; Saleh E; El-Awady R
    Ann Med; 2023 Dec; 55(1):2203946. PubMed ID: 37092854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia.
    Zhou L; Jia X; Shang Y; Sun Y; Liu Z; Liu J; Jiang W; Deng S; Yao Q; Chen J; Li H
    Mol Carcinog; 2023 Aug; 62(8):1119-1135. PubMed ID: 37144835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noncoding RNAs in cancer ferroptosis: From biology to clinical opportunity.
    Shan C; Liang Y; Wang K; Li P
    Biomed Pharmacother; 2023 Sep; 165():115053. PubMed ID: 37379641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging insights: miRNA modulation of ferroptosis pathways in lung cancer.
    Elsakka EGE; Midan HM; Abulsoud AI; Fathi D; Abdelmaksoud NM; Abdel Mageed SS; Zaki MB; Abd-Elmawla MA; Rizk NI; Elrebehy MA; Abdelghany TM; Elesawy AE; Shahin RK; El Tabaa MM; Mohammed OA; Abdel-Reheim MA; Elballal MS; Doghish AS
    Exp Cell Res; 2024 Oct; 442(2):114272. PubMed ID: 39362302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nrf2 targeting in overcoming ferroptosis evasion in head and neck cancer.
    Roh JL
    Biochem Biophys Res Commun; 2023 Sep; 671():225-228. PubMed ID: 37307705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutritional and Metabolic Control of Ferroptosis.
    Mishima E; Conrad M
    Annu Rev Nutr; 2022 Aug; 42():275-309. PubMed ID: 35650671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulation of different modes of programmed cell death by epigenetic modifications and their role in cancer.
    Damiescu R; Efferth T; Dawood M
    Cancer Lett; 2024 Mar; 584():216623. PubMed ID: 38246223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Regulation Role of Ferroptosis Mechanism of Anti-Cancer Drugs and Noncoding RNAs.
    Ensoy M; Bumin ZS; Jama HA; Cansaran-Duman D
    Curr Med Chem; 2023; 30(14):1638-1656. PubMed ID: 35770401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of Ferroptosis by microRNAs in Human Cancer.
    Velkova I; Pasino M; Khalid Z; Menichini P; Martorana E; Izzotti A; Pulliero A
    J Pers Med; 2023 Apr; 13(5):. PubMed ID: 37240889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers.
    Yen CY; Huang HW; Shu CW; Hou MF; Yuan SS; Wang HR; Chang YT; Farooqi AA; Tang JY; Chang HW
    Cancer Lett; 2016 Apr; 373(2):185-92. PubMed ID: 26808576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ferroptosis in Cancer Progression: Role of Noncoding RNAs.
    Zuo YB; Zhang YF; Zhang R; Tian JW; Lv XB; Li R; Li SP; Cheng MD; Shan J; Zhao Z; Xin H
    Int J Biol Sci; 2022; 18(5):1829-1843. PubMed ID: 35342359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer.
    Tousignant KD; Rockstroh A; Poad BLJ; Talebi A; Young RSE; Taherian Fard A; Gupta R; Zang T; Wang C; Lehman ML; Swinnen JV; Blanksby SJ; Nelson CC; Sadowski MC
    Cancer Metab; 2020; 8():11. PubMed ID: 32577235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.
    Lee J; You JH; Kim MS; Roh JL
    Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ferroptosis and EMT: key targets for combating cancer progression and therapy resistance.
    Ren Y; Mao X; Xu H; Dang Q; Weng S; Zhang Y; Chen S; Liu S; Ba Y; Zhou Z; Han X; Liu Z; Zhang G
    Cell Mol Life Sci; 2023 Aug; 80(9):263. PubMed ID: 37598126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.